Table 3 Fibrosis and steatosis grade at the baseline and at week 12 by placebo and treatment groups.

From: The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A

Variables

Soy isoflavone group

P valuea

Placebo group

P valuea

P valueb

Baseline

After 12 weeks

Baseline

After 12 weeks

Fibrosis grade

 Grade1

19 (76.0)

21 (84.0)

0.143

16 (76.20)

16 (76.20)

1.000

0.523

 Grade 2

3 (12.0)

3 (12.0)

4 (19.0)

4 (19.0)

 Grade 3

3 (12.0)

1 (4.0)

1 (4.80)

1 (4.80)

Steatosis grade

 Grade 0

0

6 (24.0)

0.001

0

1 (4.80)

1.000

0.005

 Grade 1

0

4 (16.0)

0

1 (4.80)

 Grade 2

10 (40.0)

7 (28.0)

9 (42.90)

4 (19.0)

 Grade 3

15 (60.0)

8 (32.0)

12 (57.10)

15 (71.40)

  1. Data are presented as number (percentage).
  2. aP value obtained from Wilcoxon test.
  3. bP value obtained from Mann–Whitney test.
Back to article page